Et lavt antal patienter i kliniske studier for svær sepsis har dog tidligere gennemgået et forløb med drotrecogin alfa (aktiveret).
However, a small number of patients in severe sepsis controlled clinical trials received a prior course of drotrecogin alfa (activated).